PerYacell | MSC Exosome Manufacturing

Who We Are

Founded on Science, Driven by Standards

Peryacell — Biotechnology with Precision

PerYacell is a biotechnology company dedicated to the scalable manufacturing and clinical translation of human mesenchymal stem cell (MSC)-derived exosomes. Founded in January 2024 and headquartered in Nanjing, China, we bridge the gap between cutting-edge cell science and industrial-grade production.

Built upon the shared infrastructure of the Xingtai Rong Bioreagent Industrial Cluster (backed by Nanjing Xingong Investment Group) and in collaboration with the State Key Laboratory of Pharmaceutical Biotechnology at Nanjing University, PerYacell possesses a robust capability chain from fundamental research to commercial-scale manufacturing.

Within just two years, we have filed multiple invention patents — several already granted — and obtained ethical approval from leading tertiary hospitals for clinical investigations.

Technology Platform

GMP-Compliant, End-to-End Control

Every step — from donor tissue to final exosome product — is independently developed and controlled in-house, ensuring full traceability and clinical-grade consistency.

Umbilical Cord
(Wharton's Jelly)

→

Tissue Extraction

→

Cell Culture
(Serum-Free CD Medium)

→

Cell Harvest &
Supernatant Collection

→

TFF Purification

→

Exosome
Final Product

Traceable Umbilical Cord Donors

Every cord tissue source is documented and traceable, forming the foundation of our quality system — fully aligned with CFDA clinical standards.

Traceable Three-Tiered Master Cell Bank

Master, Working, and End-of-Production cell banks — all fully traceable, ensuring batch-to-batch reproducibility.

Serum-Free Chemically Defined Medium

No animal serum. No undefined components. A fully synthetic, chemically defined culture system that eliminates variability and enhances safety.

DMSO-Free Cryopreservation

Our cryopreservation solution eliminates DMSO, reducing cytotoxicity and improving post-thaw viability — compliant with clinical-grade expectations.

TFF-Based Exosome Purification

Tangential flow filtration (TFF) enables scalable, gentle, and reproducible exosome purification without compromising vesicle integrity.

GMP Grade A+B+C Facilities

Our cell culture and processing suites are designed and operated under GMP-compliant Grade A+B+C conditions.

What We Offer

Three Pillars of Value Creation

From raw material supply to full-service clinical development, we provide flexible partnership models tailored to your needs.

🧬

Raw Material Supply

High-quality, GMP-grade MSC-derived exosome raw materials for global markets including the United States, Japan, and beyond.

GMP GradeGlobal Export

🔬

Pipeline Development

Customized product and pipeline development in partnership with biopharma companies and research institutions.

Custom R&DCo-Development

🏥

Clinical Translation

Investigator-initiated trials (IITs) across multiple therapeutic indications with ethical approvals from leading tertiary hospitals.

IIT ApprovedMulti-Indication

Credentials & Milestones

Built on Trust, Backed by Evidence

📋

Ethical Approval

From leading tertiary hospitals

📝

Clinical Registration

Filed with National Platform

🏅

Patents Granted

Multiple invention patents

🏛️

NJU Partnership

State Key Lab

Insights

Perspectives from Our Lab

Articles, technical notes, and industry perspectives on exosome science, MSC biology, and bioprocess development.

🧬

Coming Soon

Chemically Defined Media in MSC Culture

Why moving away from serum is a scientific necessity for reproducible exosome production.

🔬

Coming Soon

TFF vs. Ultracentrifugation

A technical comparison of purification methods and why scalability matters from day one.

🌍

Coming Soon

Regulatory Expectations for Exosome Therapeutics

An overview of the evolving global regulatory landscape for exosome products.

Get in Touch

Let's Explore What's Possible

Whether you're looking for exosome raw materials, exploring co-development, or interested in clinical collaboration — we welcome the conversation.

info@peryacell.com

Location

Nanjing, China

Coming soon